1. Surgery and Evidence-based Treatments in Patients with Newly Diagnosed High-grade Glioma
- Author
-
Jacqueline Behr and Jennifer Serventi
- Subjects
Oncology ,Adult ,Male ,medicine.medical_specialty ,Evidence-based practice ,medicine.medical_treatment ,Newly diagnosed ,03 medical and health sciences ,0302 clinical medicine ,Glioma ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,High-Grade Glioma ,Aged ,Aged, 80 and over ,Temozolomide ,Evidence-Based Medicine ,Oncology (nursing) ,business.industry ,Brain Neoplasms ,Oncology Nursing ,Standard of Care ,Middle Aged ,medicine.disease ,Combined Modality Therapy ,Radiation therapy ,Regimen ,030220 oncology & carcinogenesis ,Female ,business ,Adjuvant ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Objective To describe the currently accepted standard-of-care practice for surgical and medical management of newly diagnosed high-grade glioma. Data Sources Peer-reviewed journals, nationally accepted guidelines, and personal experience of the authors. Conclusion There is a widely accepted standard-of-care treatment protocol for patients with newly diagnosed high-grade glioma that includes maximal safe resection followed by radiation therapy with concurrent and adjuvant temozolomide. The regimen is well-tolerated and side effects are manageable. Implications for Nursing Practice Nurses who are involved in the care of patients with newly diagnosed high-grade glioma should be familiar with the regimen and its side effects to provide crucial patient and caregiver education in an accurate and beneficial manner.
- Published
- 2018